Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s):  CLAZF

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID... see more

TSXV:CLAS.H - Post Discussion

Claritas Pharmaceuticals Inc > Company doing 2 nr with same info few hrs apart
View:
Post by edrose on Mar 04, 2021 3:52pm

Company doing 2 nr with same info few hrs apart

Desperate pumping they need concrete nr
Comment by Moonshiner592 on Mar 04, 2021 4:00pm
  Ed the sock !! 
Comment by WORKINMONTANA on Mar 04, 2021 4:11pm
Comment by Enzolini on Mar 04, 2021 4:20pm
They put lipstick on a pig!!! These NRs make no sense at all. Investors understand how you work Robert, private placement coming very soon. No difference then before. Will never see ten cents again!
Comment by Infoiskeyforall on Mar 04, 2021 4:37pm
Great info, not! They have received grants from the Aussie government and probably pretty close to finishing phase 1, glta.  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities